Compendial Product Licence Applications: Completeness Checklist
The Natural Health Products Directorate (NHPD) has changed its name to the Natural and Non-prescription Health Products Directorate (NNHPD) subsequent to its recently expanded mandate to include the oversight of non-prescription and disinfectant drugs in addition to natural health products (NHPs). Please note that we are currently modifying documents to reflect this change.
Thank you for your patience and understanding.
Health Canada has amended the Natural Health Products Regulations. For more information and to access the supporting Labelling of Natural Health Products guidance document, visit What's new: Natural and non-prescription health products.
This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.
March 2008 - Version 3.0
The following checklist is a resource tool to be used by applicants intending to submit a compendial product licence application (PLA) for a NHP. This list is also used internally by Health Canada during the review of compendial applications.
Compendial product licence applications are those where the applicant is referencing an official NNHPD monograph published in the Compendium of Monographs. In accordance with section 6 of the Natural Health Products Regulations, compendial product licence applications are processed within 60-days of receipt.
Applicants are encouraged to carefully review their product licence applications prior to submission to ensure that all necessary information has been provided. This checklist can be used during the revision process to help applicants ensure that their compendial PLAs have been properly filled out.
Key Point When Preparing a Compendial Product Licence Application
The information provided in the application (e.g. source information, proper name, common name, etc.) must match the information found in the referenced monograph. Deviations of any kind from the referenced monograph are not acceptable for compendial product licence applications and will result in refusal.
Additional resources for compendial product licence applicants:
Compendial Completeness Checklist (11 Items in total)
Product Licence Application Form Requirements:
Item 1
1. There exists a NNHPD monograph (published in the Compendium of Monographs) for the medicinal ingredient or product indicated on the product licence application form (PLA).
If the Compendium of Monographs does not include a monograph for your medicinal ingredient or product, you cannot submit a compendial product licence application for your product.
NOTE: NHPs that contain multiple medicinal ingredients that are monographed individually are not considered compendial products and applicants cannot submit a compendial product licence application (since a combination rationale is required).
- Yes
- No
Item 2
2. The brand name(s) indicated on the PLA does not/do not contravene Section 9 of the Food and Drugs Act.
Section 9(1) of the Food and Drugs Act states that "No person shall label, package, treat, process, sell or advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety."
- Yes
- No
Item 3
3. The medicinal ingredient(s) on the PLA is/are acceptable as per the referenced monograph.
- Yes
- No
Item 4
4. The non-medicinal ingredient(s) on the PLA is/are acceptable as per the referenced monograph.
- Yes
- No
Item 5
5. The recommended dose on the PLA is acceptable as per the referenced monograph.
- Yes
- No
Item 6
6. The recommended conditions of use* on the PLA are acceptable as per the referenced monograph.
* "Recommended conditions of use" includes the following:
- Use(s) or Purpose(s)
- Dosage form
- Route of administration
- Duration of use
- Risk information
- Yes
- No
Labelling Requirements:
Item 7
7. The label text is acceptable as per Sections 88, 89, 91, 93, 94 (if applicable) and 95 of the Natural Health Products Regulations.
Health Canada has amended the Natural Health Products Regulations. For more information and to access the supporting Labelling of Natural Health Products guidance document, visit What's new: Natural and non-prescription health products.
Applicants may refer to the Labelling of Natural Health Products guidance document for further information on the labelling requirements for NHPs. Specifically:
- Chapter 2.1, and 2.2 and 2.3 for inner and outer label requirements (section 93 of the Regulations)
- Chapter 5.3 for small packaging labelling requirements (section 94 of the Regulations)
- Chapter 3.3 for security labelling requirements (section 95 of the Regulations)
- Yes
- No
Item 8
8. The information on the label text is identical to the Product Licence Application form.
- Yes
- No
Item 9
9. The advertising on the label does not contravene Section 9 of the Food and Drugs Act.
Section 9(1) of the Food and Drugs Act states that "No person shall label, package, treat, process, sell or advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety.
- Yes
- No
Animal Tissue Form Requirements (if necessary):
Item 10
10. A complete Animal Tissue form has been provided for all ingredients sourced from animal material(s).
- Yes
- No
Item 11
11a. There are BSE/TSE risks associated with the Animal Tissue form(s) provided.
- Yes
- No
11b. If the answer to item 11a is "yes", additional information demonstrating how the risks of BSE/TSE are mitigated has been provided with the application*.
Further guidance is available in the Revised Policy Regarding Gelatin in Natural Health Products
- Yes
- No
Answering "No" to any of the 11 items listed above (with the exception of item 11a) means that the compendial application is incomplete and will be refused by NNHPD. If you answer "Yes" to Item 11a, you must answer "Yes" to Item 11b and provide additional information demonstrating how the risks of BSE/TSE are mitigated. Answering "No" to Item 11b will result in the refusal of the application.
Page details
- Date modified: